Article
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML).
Leukemia - 1 Apr 2021
Yun Seongseok, Geyer Susan M, Komrokji Rami S, Al Ali Najla H, Song Jinming, Hussaini Mohammad, Sweet Kendra L, Lancet Jeffrey E, List Alan F, Padron Eric, Sallman David A
Abstract excerpt
The implementation of next-generation sequencing (NGS) has influenced diagnostic, prognostic, and therapeutic decisions in myeloid malignancies. However, the clinical relevance of serial molecular annotation in patients with myelodysplastic syndrome (MDS) undergoing active treatment is unknown. MDS or secondary acute myeloid leukemia (sAML) patients who had at least two NGS assessments were identified. Outcomes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
